WILMINGTON, Del., Feb. 12, 2016 -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD)?
- Did you purchase your shares between October 15, 2013 and February 1, 2016, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Central District of California on behalf of all persons or entities that purchased the common stock of Aerojet Rocketdyne Holdings, Inc. (“Aerojet” or the “Company”) (NYSE:AJRD) between October 15, 2013 and February 1, 2016, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you purchased shares of Aerojet during the Class Period, or purchased shares prior to the Class Period and still hold Aerojet, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/aerojet-rocketdyne-holdings-inc-ajrd.
The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. As a result of defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.
According to the Complaint, on February 1, 2016, after the market closed, the Company filed a Form 8-K with the SEC disclosing that consolidated financial statements as of and for the fiscal years ended November 30, 2013 and 2014, and the consolidated financial statements as of and for the quarter ended August 31, 2013, and the consolidated financial statements as of and for the quarters ended February 28, May 31 and August 31, 2014 and 2015 and should no longer be relied upon.
On this news, shares of Aerojet dropped over 3%, closing at $14.68 per share on February 2, 2016.
If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Italy Fines Apple €98.6 Million Over App Store Dominance
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



